Cargando…
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems
Previous studies have estimated that patients served by health systems accrue 59‐98% of the value generated by new pharmaceuticals. This has led to questions about whether sufficient returns accrue to manufacturers to incentivize socially optimal levels of R&D. These studies have not, however, f...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291963/ https://www.ncbi.nlm.nih.gov/pubmed/34342084 http://dx.doi.org/10.1002/hec.4393 |